The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD)

Abstract

Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged as well as concerns about potential risks with using fish oil as a monotherapy. This review will discuss the experience to date with this lipid emulsion along with the rational for its use, controversies and concerns. © 2012 by the authors; licensee MDPI, Basel, Switzerland.